Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01464398 · ClinicalTrials.gov registry record · NA

Stress Reduction for Overweight or Obese Women Either With Polycystic Ovary Syndrome (PCOS) or Without PCOS (Non-PCOS)

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
86
Enrollment target

NCT01464398: Completed NA study, sponsored by Milton S. Hershey Medical Center.

NCT01464398 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 86 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01464398, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of stress reduction on glucose, blood pressure, quality of life and overall health and well-being in overweight or obese women, either with Polycystic Ovary Syndrome (PCOS) or without PCOS (non-PCOS). Stress reduction treatment sessions will include one or more of the following activities: breathing exercises, meditation, stretching exercises or health education activities.

Interventions

  • BEHAVIORAL Stress reduction
  • BEHAVIORAL Stress reduction with Health education

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2011-11
Est. Completion 2014-06
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT01464398 record still lists

NCT01464398 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Stress reduction is the first listed.

NCT01464398 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01464398 about?

NCT01464398 is a clinical study titled "Stress Reduction for Overweight or Obese Women Either With Polycystic Ovary Syndrome (PCOS) or Without PCOS (Non-PCOS)". The purpose of this study is to determine the effects of stress reduction on glucose, blood pressure, quality of life and overall health and well-being in overweight or obese women, either with Polycystic Ovary Syndrome (PCOS) or without PCOS (non-PCOS). Stress reduction treatment sessions will incl...

What is the current status of trial NCT01464398?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2011-11. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01464398?

The interventions under investigation include: Stress reduction (BEHAVIORAL), Stress reduction with Health education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01464398?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01464398's enrollment target sits among peer trials

86 976th of 2000 higher than 1,021 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01639508 · 86 participants · Phase 2

    Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

  • NCT03519269 · 86 participants · NA

    Navio Robotic Versus Conventional Total Knee Arthroplasty

  • NCT04132999 · 86 participants · NA

    PAP for Children With DS and OSAS

  • NCT04545957 · 86 participants · NA

    Jump: MR Simulation For Radiation Therapy Master Protocol

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01464398, the US trial registry maintained by the National Library of Medicine. NCT01464398 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.